LONDON (Reuters) – Britain on Tuesday said those carrying out phase-1 clinical trials needed to have a risk assessment in place in response to the coronavirus outbreak or they could be halted, though the action does not affect COVID-19 trials.
“We have written to all Phase I accredited units conducting early phase clinical trials to seek confirmation that all trials have undergone a risk assessment in relation to coronavirus (COVID-19) and the current government advice,” the government said.
“It is important to stress that this action is not applicable to ongoing or proposed clinical trials related to COVID-19.”
(Reporting by Guy Faulconbridge and Kate Holton)
